Zinc oxide
Drug profile
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Zinc oxide is a drug catalogued in DrugCentral. It was first approved by the FDA in 2006. Recorded indications include Arthropod bite wound, Burn injury, Candidiasis of skin and Diaper rash.
- Indications: Arthropod bite wound, Burn injury, Candidiasis of skin, Diaper rash and Eruption of skin and others.
- Molecular formula: OZn; molecular weight 81.38 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (17)
- Arthropod bite wound
- Burn injury
- Candidiasis of skin
- Diaper rash
- Eruption of skin
- Hemorrhoids
- Itching of skin
- Minor Bacterial Skin Infections
- Pityriasis versicolor
- Proctitis
- Pruritus ani
- Rectal pain
- Skin irritation
- Tinea corporis
- Tinea cruris
- Tinea pedis
- Wound
Off-label uses (1)
- Paronychia
Contraindications (14)
- Anemia due to enzyme deficiency
- Anxiety
- Benign prostatic hyperplasia
- Conduction disorder of the heart
- Denuded skin
- Disorder of coronary artery
- Hb SS disease
- Hemochromatosis
- Hypertensive disorder
- Hyperthyroidism
- Nervousness
- Open wound
- Primary hyperoxaluria
- Wilson's disease
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2006-02-16 | FDA | — | DELCOR ASSET |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Systemic lupus erythematosus | 2727.0 |
| Pemphigus | 2694.9 |
| Glossodynia | 2341.9 |
| Hand deformity | 2014.6 |
| Arthropathy | 1948.3 |
| Alopecia | 1768.0 |
| Abdominal discomfort | 1728.9 |
| Wound | 1662.0 |
| Synovitis | 1566.6 |
| Toxicity to various agents | 1562.3 |
| Maternal exposure during pregnancy | 1521.5 |
| Anti-cyclic citrullinated peptide antibody positive | 1353.5 |
Chemical structure
| Molecular formula | OZn |
|---|---|
| Molecular weight | 81.38 g/mol |
| CAS number | 1314-13-2 |
| InChIKey | XLOMVQKBTHCTTD-UHFFFAOYSA-N |
| PubChem CID | 3007857 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Zinc oxide used for?
DrugCentral lists the following indications for Zinc oxide: Arthropod bite wound, Burn injury, Candidiasis of skin, Diaper rash, Eruption of skin, Hemorrhoids, Itching of skin and Minor Bacterial Skin Infections and others.
When was Zinc oxide first approved?
Zinc oxide was first approved by the FDA in 2006.
What is the chemical formula of Zinc oxide?
Zinc oxide has the molecular formula OZn and a molecular weight of 81.38 g/mol.
Browse: all drugs starting with Z · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4240 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3988900 — compound record and bioactivity
- PubChem CID 3007857 — chemical identifiers
- DrugBank DB09321 — drug record
- FDA UNII SOI2LOH54Z — substance identity
- DailyMed: FDA labels for Zinc oxide — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.